Related Experiment Video

Updated: Sep 28, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.8K

Molecular and cellular mechanisms of melatonin in breast cancer

Fatemeh Sadoughi1, Parisa Maleki Dana1, Zatollah Asemi2

  • 1Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, I.R., Iran; Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran.

Biochimie
|March 28, 2022
PubMed

Insights

Melatonin shows promise as a novel breast cancer treatment. This review explores its potential therapeutic effects, suggesting it may offer a safer alternative to chemotherapy.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Breast cancer presents a significant global health challenge with high mortality rates.
  • Despite advancements, there's a critical need for more effective breast cancer treatments.
  • Melatonin, a versatile molecule, influences numerous cellular processes, making it a potential anti-cancer agent.

Purpose of the Study:

  • To review existing evidence on melatonin's effects in breast cancer.
  • To highlight melatonin as a potential therapeutic agent for breast cancer.
  • To provide a new perspective on breast cancer treatment strategies using melatonin.

Main Methods:

  • Literature review of studies investigating melatonin and breast cancer.
  • Synthesis of evidence regarding melatonin's biological activities.
  • Analysis of current research trends in melatonin-based cancer therapy.

Main Results:

  • Melatonin exhibits properties that suggest efficacy in targeting breast cancer.
  • Research is increasingly focusing on melatonin's specific role in breast cancer.
  • Evidence suggests melatonin could be a valuable component of breast cancer treatment.

Conclusions:

  • Melatonin is a promising candidate for novel breast cancer therapies.
  • Further research may establish melatonin as a common therapeutic drug with fewer side effects than traditional chemotherapy.
  • Melatonin-based treatments could offer a safer, more effective approach to managing breast cancer.
Keywords:
Breast cancerMelatoninNF-κB signaling pathway

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.3K
In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells11:56

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells

Published on: September 28, 2017

10.0K

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
331
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K